Skip to content

Effects of Dietary Fiber on Insulin Sensitivity

Effects of Dieatry Fiber on Insulin Sensitivity in Pre- and Post-menopausal Women

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01521806
Enrollment
40
Registered
2012-01-31
Start date
2012-01-31
Completion date
2013-09-30
Last updated
2012-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focus of the Study is Insulin Sensitivity

Keywords

insulin sensitivity, resistant starch

Brief summary

This study will examine the effects of a dietary fiber on insulin sensitivity in overweight and obese women. The fiber will be added to snack foods and women will consume the foods for four weeks. In one four-week period, 15 g of fiber will be added, and 30 g will added in another period. In a third period, no fiber will be added to the snack foods. Insulin senstivity will be measured at the end of each treatment period.

Interventions

DIETARY_SUPPLEMENTDietary Fiber

Dietary fiber will be added to snack foods

Sponsors

Ingredion Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Impaired fasting glucose * Overweight and obese

Exclusion criteria

* Diabetes, Presence of chronic diseases

Design outcomes

Primary

MeasureTime frameDescription
Insulin sensitivity5-hr test, performed 3 times within a 20-week periodA frequently sampled intravenous blood glucose tolerance test will be performed.

Secondary

MeasureTime frameDescription
Mitocondrial function3 times, with a 20-week periodA muscle biospy will be taken to assess mitochondrial function
Meal tolerance test3 times, within a 20-week periodA high-fat meal will be given and blood will be drawn over a three-hr period

Countries

United States

Contacts

Primary ContactBrandon Kane
kane003@uab.edu205-975-9629

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026